These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22275743)

  • 1. Atrial fibrillation and thromboembolic risk in Greece.
    Korantzopoulos P; Andrikopoulos G; Vemmos K; Goudevenos JA; Vardas PE
    Hellenic J Cardiol; 2012; 53(1):48-54. PubMed ID: 22275743
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of atrial fibrillation burden in assessing thromboembolic risk.
    Zimetbaum P; Waks JW; Ellis ER; Glotzer TV; Passman RS
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1223-9. PubMed ID: 25516580
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
    Watson T; Shantsila E; Lip GY
    Int J Cardiol; 2007 Aug; 120(1):123-4; author reply 125-6. PubMed ID: 17055595
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulant treatment in the prophylaxis of thromboembolic complications in atrial fibrillation].
    Skrakova M; Sujanova Z
    Bratisl Lek Listy; 2001; 102(5):268-70. PubMed ID: 11725382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for atrial fibrillation and its impact on public health.
    Lam A; Goulouti E; Roten L
    Swiss Med Wkly; 2017; 147():w14447. PubMed ID: 28695554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nonpharmacological methods of prevention of thromboembolic complications in patients with atrial fibrillation].
    Zhirov IV; Cherkavskaia OV; Rudenko BA; Osmolovskaia IuF; Gerasimov AM; Savchenko AP; Tereshchenko SN
    Kardiologiia; 2012; 52(9):64-8. PubMed ID: 23098548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atrial fibrillation. Risk of thromboembolic complications and their prevention].
    Petersen P; Kastrup J; Bartram R; Godtfredsen J
    Ugeskr Laeger; 1984 Mar; 146(11):789-92. PubMed ID: 6719572
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of risk of thromboembolism in atrial fibrillation: which patients should be anticoagulated?
    Lip GY
    Eur Heart J; 1999 Dec; 20(23):1757-8. PubMed ID: 10562485
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of thromboembolic complication in atrial fibrillation by using anticoagulants.
    Wagh K; Vikhe VB; Kumar RS; Auti N; Jose M
    J Assoc Physicians India; 2013 Dec; 61(12):894-5. PubMed ID: 24968545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with atrial fibrillation and CHA2DS2-VASc score 1: "To anticoagulate or not to anticoagulate? That is the question!".
    Patti G; Cavallari I
    Heart Rhythm; 2015 Dec; 12(12):2515-20. PubMed ID: 26188249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation in people with atrial fibrillation.
    Fang MC
    BMJ; 2011 Jan; 342():d530. PubMed ID: 21282259
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulation in atrial fibrillation.
    Huerta BJ; Lemberg L
    Heart Lung; 1985 Sep; 14(5):521-3. PubMed ID: 3849534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.
    Wipf JE
    West J Med; 1995 Aug; 163(2):145-52. PubMed ID: 7571562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Olesen JB; Fauchier L; Lane DA; Taillandier S; Lip GYH
    Chest; 2012 Jan; 141(1):147-153. PubMed ID: 21680645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk of thromboembolism in atrial fibrillation].
    Csanádi Z
    Orv Hetil; 2016 Sep; 157(38):1511-5. PubMed ID: 27640617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New oral anticoagulants and thromboembolism prevention in atrial fibrillation].
    Zhu J; Yang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):370-1. PubMed ID: 25042911
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct oral anticoagulants for the prevention of thromboembolic complications of atrial fibrillation: The more you pay, the less you spend?
    Brunetti ND; De Gennaro L; Caldarola P; Gaglione A; Di Biase M
    Int J Cardiol; 2017 Aug; 241():238-240. PubMed ID: 28363685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.